These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8130156)

  • 21. When will we eliminate folic acid-preventable spina bifida?
    Oakley GP
    Epidemiology; 2007 May; 18(3):367-8. PubMed ID: 17435446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are encephaloceles neural tube defects?
    Rowland CA; Correa A; Cragan JD; Alverson CJ
    Pediatrics; 2006 Sep; 118(3):916-23. PubMed ID: 16950981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal hydrocephalus. Clinical significance of associated anomalies and genetic counseling: a pathological approach.
    Roume J; Larroche JC; Razavi-Encha F; Gonzales M; Migne G; Mulliez N
    Genet Couns; 1990; 1(3-4):185-96. PubMed ID: 2098043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity and recurrence risk for congenital hydrocephalus (ventriculomegaly): a prospective study.
    Váradi V; Tóth Z; Török O; Papp Z
    Am J Med Genet; 1988 Feb; 29(2):305-10. PubMed ID: 3354602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Micronutrients in pregnancy].
    Pietrzik K; Prinz-Langenohl R; Thorand B
    Z Geburtshilfe Neonatol; 1997; 201 Suppl 1():21-4. PubMed ID: 9410525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural tube defects in Havana City--incidence and prenatal diagnosis.
    Rodriguez PL; Heredero B; Lopez J; Fernandez Yero JL; Oliva RJ
    Zentralbl Gynakol; 1982; 104(20):1325-7. PubMed ID: 6186106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are the neurulation and canalization forms of neural tube defects causally distinct?
    Török O; Papp Z
    Am J Med Genet; 1991 May; 39(2):241. PubMed ID: 2063937
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for multi-site closure of the neural tube in humans.
    Van Allen MI; Kalousek DK; Chernoff GF; Juriloff D; Harris M; McGillivray BC; Yong SL; Langlois S; MacLeod PM; Chitayat D
    Am J Med Genet; 1993 Oct; 47(5):723-43. PubMed ID: 8267004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Folic acid in the prevention of neural tube defects].
    Tönz O; Lüthy J; Raunhardt O
    Schweiz Med Wochenschr; 1996 Feb; 126(5):177-87. PubMed ID: 8685688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Folic acid and the risk of neural tube defects].
    Kihlberg R; Bui TH; Nielsen T; Söderhjelm L
    Lakartidningen; 2001 May; 98(18):2233. PubMed ID: 11402606
    [No Abstract]   [Full Text] [Related]  

  • 31. Trisomy 13 syndrome and neural tube defects.
    Rodríguez JI; García M; Morales C; Morillo A; Delicado A
    Am J Med Genet; 1990 Aug; 36(4):513-6. PubMed ID: 2202219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse Fkbp8 activity is required to inhibit cell death and establish dorso-ventral patterning in the posterior neural tube.
    Wong RL; Wlodarczyk BJ; Min KS; Scott ML; Kartiko S; Yu W; Merriweather MY; Vogel P; Zambrowicz BP; Finnell RH
    Hum Mol Genet; 2008 Feb; 17(4):587-601. PubMed ID: 18003640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid.
    Zlotogora J; Amitai Y; Leventhal A
    Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Isolated" hydrocephalus in families of spina bifida and anencephaly: a coincidence?
    Journel H; Parent P; Roussey M; LeMarec B
    Neuropediatrics; 1989 Nov; 20(4):220-2. PubMed ID: 2691919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward understanding the genetic basis of neural tube defects.
    Kibar Z; Capra V; Gros P
    Clin Genet; 2007 Apr; 71(4):295-310. PubMed ID: 17470131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification.
    Bower C; D'Antoine H; Stanley FJ
    Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):269-73. PubMed ID: 19180646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects.
    Volcik KA; Shaw GM; Lammer EJ; Zhu H; Finnell RH
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):154-7. PubMed ID: 12797455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence risk in hydrocephalus.
    Bay C; Kerzin L; Hall BD
    Birth Defects Orig Artic Ser; 1979; 15(5C):95-105. PubMed ID: 526618
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence and outcome of congenital heart disease in patients with neural tube defect.
    Koçak G; Onal C; Koçak A; Karakurt C; Ates O; Cayli SR; Yologlu S
    J Child Neurol; 2008 May; 23(5):526-30. PubMed ID: 18056696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should folic acid fortification be mandatory in Israel?
    Hacohen Y; Lerman-Sagie T
    Isr Med Assoc J; 2006 Sep; 8(9):649-50. PubMed ID: 17058420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.